Akebia Therapeutics's total assets for Q2 2025 were $345.60M, an increase of 11.42% from the previous quarter. AKBA total liabilities were $316.37M for the fiscal quarter, a 10.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.